Allergan chief executive David Pyott said he probably won’t follow other drugmakers in making an acquisition in Ireland as a way to lower the company’s corporate taxes.

ELAN Corp investor Ib Sonderby has proposed four candidates for the Irish drugmaker’s board, including Athena Neurosciences co-founder Larry Fritz.